SCHEMBL2405951

SCHEMBL2405951

C1=C\N=C/c2ccccc2\C=N/1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 3/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.30
▸ MAPT P10636 2/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ TSHR P16473 2/20 0.30
▸ LMNA P02545 1/20 0.30
▸ ALOX12 P18054 1/20 0.30
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2405953 1.00 TRPA1 (0.32) TRPA1CYP3A4ALOX15CASP1CASP7
SCHEMBL8134246 0.79 — —
SCHEMBL206344 0.79 TRPA1 (0.34) TRPA1
SCHEMBL8134253 0.79 — —
SCHEMBL686917 0.78 — —
SCHEMBL18425441 0.74 — —
SCHEMBL11150811 0.73 KDM4E (0.37) ALOX15KDM4EMAPTALDH1A1HPGD
SCHEMBL211612 0.72 GAA (0.36) MAPTGAA
SCHEMBL38113 0.72 TRPA1 (0.41) TRPA1
SCHEMBL18699163 0.71 TRPA1 (0.37) TRPA1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0089743-B1 NOVEL 2,5-BENZODIAZOCINES AND SALTS THEREOF HAVING PHARMACEUTICAL ACTIVITY SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1986-12-10 — — EP claimed
US-4435392-A 2,5-Benzodiazocine derivatives and salts thereof, as well as pharmaceutical agent comprising as effective component at least one of the derivatives and salts SANWA KAGAKU KENKYUSHO CO. LTD. (JP) 1984-03-06 — — US claimed
EP-0089743-A1 Novel 2,5-benzodiazocines and salts thereof having pharmaceutical activity SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1983-09-28 — — EP claimed
EP-2542545-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE Merck Sharp & Dohme Corp. (US) 2013-01-09 — — EP disclosed
WO-2011106992-A1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE MERCK SHARP & DOHME CORP. (US) 2011-09-09 — — WO disclosed
US-5268372-A Where nitrogen in position 2 and 5 are connected by a methylene bridge STERLING WINTHROP INC. (US) 1993-12-07 — — US disclosed
US-5268372-A Where nitrogen in position 2 and 5 are connected by a methylene bridge STERLING WINTHROP INC. (US) 1993-12-07 — — US disclosed
US-5268372-A Where nitrogen in position 2 and 5 are connected by a methylene bridge STERLING WINTHROP INC. (US) 1993-12-07 — — US disclosed
US-5206231-A 2,5-benzodiazocine antiarrhythmic agents STERLING DRUG INC. (US) 1993-04-27 — — US disclosed
US-5206231-A 2,5-benzodiazocine antiarrhythmic agents STERLING DRUG INC. (US) 1993-04-27 — — US disclosed
US-5206231-A 2,5-benzodiazocine antiarrhythmic agents STERLING DRUG INC. (US) 1993-04-27 — — US disclosed
EP-0089743-B1 NOVEL 2,5-BENZODIAZOCINES AND SALTS THEREOF HAVING PHARMACEUTICAL ACTIVITY SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1986-12-10 — — EP disclosed
EP-0089743-B1 NOVEL 2,5-BENZODIAZOCINES AND SALTS THEREOF HAVING PHARMACEUTICAL ACTIVITY SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1986-12-10 — — EP disclosed
US-4435392-A 2,5-Benzodiazocine derivatives and salts thereof, as well as pharmaceutical agent comprising as effective component at least one of the derivatives and salts SANWA KAGAKU KENKYUSHO CO. LTD. (JP) 1984-03-06 — — US disclosed
US-4435392-A 2,5-Benzodiazocine derivatives and salts thereof, as well as pharmaceutical agent comprising as effective component at least one of the derivatives and salts SANWA KAGAKU KENKYUSHO CO. LTD. (JP) 1984-03-06 — — US disclosed
US-4435392-A 2,5-Benzodiazocine derivatives and salts thereof, as well as pharmaceutical agent comprising as effective component at least one of the derivatives and salts SANWA KAGAKU KENKYUSHO CO. LTD. (JP) 1984-03-06 — — US disclosed
EP-0089743-A1 Novel 2,5-benzodiazocines and salts thereof having pharmaceutical activity SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1983-09-28 — — EP disclosed
EP-0089743-A1 Novel 2,5-benzodiazocines and salts thereof having pharmaceutical activity SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1983-09-28 — — EP disclosed
EP-0089743-A1 Novel 2,5-benzodiazocines and salts thereof having pharmaceutical activity SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1983-09-28 — — EP disclosed
US-3994920-A APPETITE SUPPRESSANT, ANTIDEPRESSANT AMERICAN HOME PRODUCTS CORPORATION (US) 1976-11-30 — — US disclosed
Send feedback